recent
relationship
evid
colon
infect
specif
microbi
speci
develop
persist
exacerb
pulmonari
diseas
inform
opinion
airway
microbiolog
howev
recent
applic
cultureindepend
tool
microbiom
profil
reveal
divers
microbiota
previous
recogn
airway
patient
chronic
pulmonari
diseas
new
evid
indic
composit
airway
microbiota
differ
state
health
diseas
sever
symptom
microbiota
collect
entiti
may
contribut
pathophysiolog
process
associ
chronic
airway
diseas
review
evolut
airway
microbiolog
studi
chronic
pulmonari
diseas
focus
asthma
chronic
obstruct
pulmonari
diseas
cystic
fibrosi
build
evid
deriv
tradit
microbiolog
approach
recent
cultureindepend
microbiom
studi
discuss
implic
recent
find
potenti
microbi
determin
respiratori
health
diseas
emerg
bodi
evid
field
human
microbi
ecolog
redefin
percept
human
superorgan
delic
balanc
exist
host
immun
respons
microbi
popul
inhabit
multipl
nich
human
host
semin
studi
gastrointestin
microbiom
obes
recent
find
link
airway
microbiom
composit
bronchial
hyperrespons
asthmat
inhal
corticosteroid
clear
chronic
inflammatori
diseas
repres
significantli
complex
interact
microbi
commun
host
inflammatori
respons
previous
appreci
review
recent
literatur
field
airway
microbiom
research
focus
first
initi
observ
spur
microbiota
investig
three
major
chronic
airway
diseas
asthma
chronic
obstruct
pulmonari
diseas
copd
cystic
fibrosi
cf
given
nascenc
airway
microbiom
research
articl
also
includ
recent
literatur
upper
airway
microbiota
state
health
diseas
find
discuss
independ
diseas
anatom
distinct
field
move
forward
unifi
theori
role
airway
microbiom
modul
chronic
airway
diseas
seem
like
emerg
given
larg
bodi
previou
literatur
provid
evid
link
specif
microbi
speci
chronic
airway
diseas
base
tradit
microbiolog
approach
key
find
asthma
copd
cf
discuss
first
acut
respiratori
infect
wellknown
trigger
asthma
exacerb
evid
colon
infect
specif
microbi
speci
also
link
develop
presenc
asthma
amongst
bacteri
speci
studi
context
atyp
organ
chlamydophila
previous
known
chlamydia
pneumonia
mycoplasma
pneumonia
despit
rel
larg
bodi
epidemiolog
literatur
investig
link
organ
chronic
asthma
evid
overal
remain
inconclus
review
sever
studi
report
serolog
evid
atyp
bacteri
infect
associ
onset
asthma
other
includ
larger
studi
pediatr
patient
newli
diagnos
asthma
match
healthi
control
patient
find
differ
serolog
preval
c
pneumoniaespecif
antibodi
regardless
differ
detect
method
use
howev
among
patient
sever
asthma
igg
seroposit
c
pneumonia
interestingli
associ
greater
estim
annual
declin
lung
function
particularli
individu
nonatop
adultonset
asthma
contribut
factor
controversi
regard
associ
atyp
bacteria
asthma
difficulti
detect
diagnos
infect
organ
laboratori
culturebas
identif
gener
repres
insensit
diagnost
tool
particularli
sinc
organ
fastidi
difficult
grow
convent
condit
thu
serolog
test
antibodi
direct
speci
commonli
employ
studi
determin
evid
infect
howev
approach
complic
variabl
avail
test
method
interpret
well
rel
high
seropreval
antibodi
organ
gener
popul
recent
sever
studi
investig
link
atyp
bacteria
asthma
appli
target
pcrbase
amplif
method
aim
detect
specif
speci
use
nucleic
acid
extract
respiratori
specimen
result
studi
support
link
presenc
atyp
bacteria
airway
sampl
chronic
asthma
though
detect
speci
use
dnabas
approach
neither
indic
viabil
organ
respiratori
tract
distinguish
state
colon
versu
infect
studi
patient
persist
asthma
healthi
control
evid
c
pneumonia
infect
induc
sputum
posit
pcr
andor
immunoglobulin
measur
frequent
asthmat
subject
particularli
poorli
control
nonatop
asthma
lower
airway
specimen
obtain
asthmat
healthi
subject
bronchoscopi
bronchial
biopsi
bronchoalveolar
lavag
fluid
also
analyz
use
speciesspecif
pcr
pneumonia
c
pneumonia
studi
asthmat
patient
pcrposit
compar
one
healthi
control
suggest
lower
airway
colon
infect
atyp
bacteria
preval
among
adult
chronic
stabl
asthma
howev
whether
organ
repres
caus
agent
biomark
distinct
airway
microbiota
yet
establish
evid
relationship
bacteri
speci
detect
respiratori
tract
asthma
develop
recent
describ
studi
neonat
hypopharyng
sampl
obtain
cultur
month
age
neonat
evid
colon
streptococcu
pneumonia
haemophilu
influenza
moraxella
catarrhali
combin
organ
colon
one
organ
significantli
associ
persist
wheez
first
year
life
preval
asthma
age
year
neonat
colon
versu
without
neonat
colon
blood
eosinophil
count
total
ige
year
age
also
significantli
increas
children
colon
neonat
one
speci
infect
bacteria
also
associ
acut
wheezi
episod
children
h
influenza
catarrhali
pneumonia
overal
odd
ratio
independ
similar
associ
observ
viral
infect
although
confirm
causal
data
collect
suggest
multipl
bacteri
speci
may
either
prognost
asthma
risk
activ
contribut
pathogen
process
associ
diseas
howev
rnabas
studi
necessari
delin
role
diseas
infect
virus
establish
caus
acut
wheez
bronchiol
asthma
exacerb
among
infant
young
children
also
link
subsequ
develop
asthma
childhood
origin
asthma
studi
among
children
follow
year
age
viral
respiratori
ill
wheez
birth
year
age
due
respiratori
syncyti
viru
rsv
rhinoviru
rv
associ
increas
risk
asthma
year
age
rsv
rv
rsv
rv
similar
observ
made
australian
studi
children
high
risk
atopi
follow
birth
year
age
birth
cohort
detect
rv
set
wheezingassoci
lower
respiratori
tract
ill
first
year
life
relat
diagnosi
asthma
age
year
posit
associ
also
report
rsv
infect
onset
asthma
children
although
greatest
risk
asthma
age
year
childhood
origin
asthma
studi
observ
rvrelat
wheez
ill
first
year
life
smaller
statist
signific
increas
asthma
risk
also
observ
rsvrelat
wheez
ill
longitudin
analys
smaller
size
birth
cohort
sweden
follow
sinc
infanc
initi
hospit
rsv
bronchiol
also
note
increas
risk
asthma
allerg
sensit
children
sequenti
evalu
recent
year
age
time
point
asthma
preval
significantli
greater
group
experienc
rsv
infect
infanc
compar
control
group
eg
vs
age
find
suggest
potenti
prolong
effect
earli
rsv
bronchiol
develop
persist
asthma
earli
adulthood
final
two
recent
discov
viral
speci
associ
acut
respiratori
ill
human
metapneumoviru
hmpv
bocaviru
consid
relat
asthma
review
research
need
defin
contribut
asthma
exacerb
well
evalu
potenti
relationship
infect
virus
risk
develop
asthma
date
one
studi
attempt
examin
latter
research
question
relat
hmpv
investig
found
hmpvassoci
bronchiol
infanc
confer
greatest
risk
diagnosi
asthma
preschool
year
interestingli
studi
observ
risk
asthma
associ
hmpv
infect
larger
note
rsvrelat
bronchiol
role
specif
microbi
speci
pathogenesi
copd
also
much
studi
past
two
decad
despit
ongo
debat
preponder
current
evid
suggest
bacteri
infect
play
caus
role
pathogenesi
acut
exacerb
role
bacteri
colon
infect
initi
develop
copd
less
clear
exacerb
associ
particular
acquisit
new
strain
h
influenza
catarrhali
pneumonia
pseudomona
aeruginosa
result
greater
airway
inflamm
compar
exacerb
associ
new
strain
analysi
exacerb
period
new
strainassoci
exacerb
demonstr
higher
level
neutrophil
elastas
sputum
well
serum
creactiv
protein
compar
exacerb
associ
new
strain
moreov
clinic
symptomolog
relat
degre
airway
inflamm
sputum
neutrophil
elastas
serum
creactiv
protein
show
strongest
correl
clinic
symptom
score
exacerb
bacteria
associ
approxim
exacerb
frequent
isol
speci
h
influenza
p
aeruginosa
increasingli
recogn
import
pathogen
copd
identifi
frequent
advanc
copd
associ
approxim
exacerb
p
aeruginosa
infect
copd
may
demonstr
shortterm
colon
follow
rapid
clearanc
case
longerterm
persist
also
may
occur
character
frequent
turnov
clone
well
intraclon
microevolut
lead
increas
mutat
rate
antibiot
resist
greater
biofilm
product
addit
bacteria
isol
acut
exacerb
includ
staphylococcu
aureu
haemophilu
haemolyticu
haemophilu
parainfluenza
bacteri
famili
enterobacteriacea
although
pathogen
role
organ
copd
unclear
enterobacteriacea
may
particular
interest
compris
larg
famili
gramneg
bacteria
tradit
associ
gi
tract
includ
mani
known
pathogen
speci
given
clinic
signific
mani
organ
outsid
respiratori
tract
detect
enterobacteriacea
patient
advanc
copd
suggest
potenti
contribut
pathogenesi
copd
acut
exacerb
virus
also
detect
acut
copd
exacerb
commonli
rhinoviru
influenza
increasingli
detect
rsv
hmpv
acut
exacerb
also
report
sever
exacerb
requir
hospit
coinfect
virus
bacteria
result
significantli
longer
hospit
stay
day
greater
declin
lung
function
sever
clinic
symptom
also
observ
among
patient
experienc
exacerb
virus
involv
clinic
associ
probabl
relat
greater
degre
airway
inflamm
seen
exacerb
involv
bacteri
viral
coinfect
suggest
relev
interact
virus
bacteria
augment
pathogen
increas
adhes
h
influenza
pneumonia
respiratori
epitheli
cell
viralmedi
upregul
bacteri
receptor
express
convers
enhanc
bind
rhinoviru
due
increas
receptor
express
induc
h
influenza
contrast
acut
exacerb
whether
microbi
colon
infect
contribut
develop
copd
establish
howev
earli
colon
airway
evid
smoker
risk
copd
well
patient
mild
copd
base
detect
bacteria
pneumonia
h
influenza
catarrhali
protect
bronchial
brush
bronchoalveolar
lavag
fluid
establish
copd
chronic
colon
bacteria
detect
patient
stabl
diseas
accompani
elev
airway
inflammatori
marker
chronic
bacteri
colon
also
associ
frequent
exacerb
greater
airflow
obstruct
contribut
progress
lung
diseas
summari
current
evid
indic
establish
presenc
chronic
bacteri
colon
patient
copd
innocu
state
probabl
contribut
develop
progress
copd
although
role
specif
bacteri
speci
copd
studi
microbi
speci
may
potenti
colon
airway
copd
particular
associ
pneumocysti
jiroveci
colon
copd
note
eukaryot
fungal
pathogen
familiar
caus
pneumonia
immunocompromis
host
pneumocysti
observ
colon
airway
patient
copd
often
healthi
control
moreov
independ
smoke
histori
preval
colon
posit
correl
degre
airflow
obstruct
therefor
sever
copd
stage
global
health
initi
obstruct
lung
diseas
find
suggest
airway
ecosystem
patient
sever
airflow
obstruct
repres
suitabl
environ
pneumocysti
colon
may
affect
copd
progress
final
asid
exacerb
littl
research
conduct
potenti
role
virus
chronic
stabl
copd
adenoviru
suggest
one
previou
studi
potenti
colon
patient
sever
emphysema
base
analysi
lung
tissu
resect
copd
patient
number
alveolar
epitheli
cell
express
adenoviru
protein
increas
fiveto
mild
sever
emphysema
respect
compar
control
author
conclud
suggest
presenc
latent
adenovir
infect
patient
cf
microbiolog
standpoint
arguabl
one
studi
chronic
airway
diseas
due
mutat
cf
transmembran
regul
gene
cf
affect
multipl
organ
though
primari
caus
mortal
chronic
airway
colon
pulmonari
failur
p
aeruginosa
primari
recogn
bacteri
pathogen
cf
airway
diseas
colon
infect
p
aeruginosa
strongli
associ
morbid
mortal
cf
antimicrobi
therapi
integr
chronic
manag
cf
larg
target
p
aeruginosa
eg
inhal
tobramycin
howev
number
bacteri
fungal
pathogen
associ
chronic
inflammatori
airway
diseas
cf
patient
interestingli
mani
infecti
agent
particular
bacteri
exhibit
agedepend
rel
abund
exampl
rel
high
number
h
influenza
detect
pediatr
patient
howev
burden
pathogen
reduc
remain
low
patient
progress
toward
adulthood
contrari
p
aeruginosa
exhibit
opposit
dynam
present
rel
low
number
younger
patient
becom
highli
preval
patient
age
diseas
progress
given
extent
microbiolog
studi
focus
cf
unsurpris
rel
larg
number
bacteri
speci
associ
pulmonari
infect
chronic
colon
patient
cohort
tabl
detail
mani
speci
clinic
relev
cf
airway
diseas
sever
case
coinfect
number
speci
observ
use
culturebas
approach
recent
number
unusu
pathogen
describ
airway
cf
patient
includ
ralstonia
speci
member
pandoraea
genu
streptococcu
milleri
group
speci
within
enterobacteriacea
specif
speci
pandoraea
apista
associ
transmiss
sever
airway
diseas
note
sever
studi
perform
use
sputum
sampl
open
possibl
oral
origin
speci
nonetheless
given
oralairway
continuum
bacteri
clearanc
particularli
compromis
cf
patient
wholli
possibl
speci
play
key
role
cf
pulmonari
diseas
addit
sinc
frequenc
recoveri
speci
cf
pulmonari
sampl
appear
increas
recent
year
organ
certainli
merit
investig
asthma
viral
infect
also
play
role
acut
cf
pulmonari
exacerb
studi
pediatr
cf
patient
sao
paulo
femal
male
sampl
obtain
particip
includ
nasopharyng
aspir
nasal
mucu
specimen
viral
analysi
addit
sputum
oropharyng
sampl
microbi
cultur
studi
examin
sampl
exacerb
clinic
stabl
state
influenza
virus
b
human
parainfluenza
virus
human
coronaviru
hmpv
adenoviru
human
bocaviru
picornaviru
use
molecularbas
quantitativepcr
assay
signific
relationship
presenc
respiratori
virus
pulmonari
exacerb
found
p
addit
specif
rhinoviru
subtyp
c
also
significantli
associ
respiratori
exacerb
p
studi
corrobor
find
demonstr
relationship
viral
infect
pulmonari
exacerb
cf
patient
recent
studi
demonstr
mechan
viral
infect
may
caus
sever
exacerb
cf
patient
perform
use
primari
cf
airway
mucocillari
differenti
epitheli
cell
line
infect
mucoid
p
aeruginosa
chattoraj
colleagu
demonstr
releas
plankton
p
aeruginosa
cell
apic
basolater
surfac
biofilm
attach
epitheli
cell
cultur
upon
superinfect
rhinoviru
presenc
freeswim
cell
coincid
increas
chemokin
product
suggest
rhinovirusdriven
releas
immunogen
p
aeruginosa
cell
may
increas
inflammatori
respons
viral
exacerb
clearli
find
implic
mix
speci
popul
known
exist
cf
airway
discuss
previou
research
chart
evid
role
specif
organ
pathogenesi
asthma
copd
cf
achiev
primarili
use
culturebas
approach
target
molecular
approach
identifi
specif
microbi
speci
sensit
method
detect
microbiota
inher
limit
result
lost
opportun
investig
potenti
relationship
broader
microbi
commun
airway
diseas
nonetheless
find
provid
foundat
appli
broader
cultureindepend
tool
interrog
microbiom
associ
chronic
inflammatori
airway
diseas
varieti
patient
popul
applic
newer
cultureindepend
tool
enabl
interrog
microbi
commun
without
prior
expect
organ
present
includ
fastidi
noncultur
speci
dramat
impact
knowledg
human
microbi
divers
varieti
organ
system
wide
appli
approach
studi
bacteri
commun
analysi
base
ribosom
rna
rrna
gene
ubiquit
bacteria
gene
compris
conserv
stretch
sequenc
use
design
univers
primer
amplifi
gene
major
known
bacteri
speci
region
interspers
variabl
sequenc
region
sequenc
use
assign
ident
phylogeni
organ
mix
commun
sever
molecular
approach
rrnabas
analysi
exist
highthroughput
tool
rrna
microarray
platform
nextgener
sequenc
applic
recent
appli
provid
profil
microbi
commun
composit
high
resolut
particular
two
complementari
approach
capac
provid
greatest
resolut
profil
bacteri
commun
contrast
studi
bacteri
commun
fewer
inroad
made
molecular
approach
global
analysi
viral
fungal
microbiota
although
recent
effort
advanc
area
recent
studi
human
microbiom
wealth
inform
emerg
divers
microbiota
specif
organ
nich
increas
effort
gain
insight
function
aspect
microbiom
better
understand
role
microbiota
diseas
pathogenesi
knowledg
come
larg
bodi
literatur
role
gut
bacteri
commun
health
diseas
contrast
knowledg
understand
airway
microbiom
health
diseas
lag
particularli
respect
lower
respiratori
tract
howev
rate
research
effort
focus
airway
microbiom
increas
recent
studi
upper
lower
airway
microbiota
context
airway
health
diseas
discuss
sampl
upper
respiratori
tract
perform
greater
eas
compar
lower
respiratori
tract
particular
relationship
oral
microbiota
periodont
diseas
examin
sever
studi
rrna
analysi
approach
result
demonstr
multipl
type
subgingivalperiodont
microbiota
import
periodont
worth
note
abund
inform
oral
microbiota
gener
past
sever
year
catalogu
human
oral
microbiom
databas
recent
effort
made
character
oral
nasopharyng
microbiota
healthi
individu
includ
bacteria
fungal
commun
zaura
et
al
sampl
sever
intraor
site
given
potenti
microbi
commun
variat
differ
oral
nich
three
healthi
subject
includ
buccal
palat
surfac
tongu
saliva
use
analysi
rrna
amplicon
librari
observ
sequenc
read
translat
higher
taxa
ie
classifi
genu
level
share
across
three
individu
suggest
core
oral
bacteri
commun
healthi
individu
predomin
taxa
streptococcu
corynebacterium
neisseria
rothia
veillonella
speci
genera
previous
identifi
oral
caviti
howev
author
acknowledg
divers
rich
oral
microbiota
probabl
underestim
studi
rel
limit
sequenc
read
depth
perform
sampl
criteria
select
sequenc
analysi
minimum
five
read
typic
approach
provid
good
inform
domin
phylotyp
given
commun
frequent
neglect
less
abund
rarer
bacteri
phylotyp
recent
shown
contribut
greatest
function
capac
given
commun
underscor
need
highresolut
profil
approach
fulli
understand
commun
structur
relationship
clinic
variabl
nonbacteri
microbiota
respiratori
tract
well
character
area
unmet
research
need
evid
involv
specif
fungal
speci
copd
cf
littl
known
airway
fungal
microbiota
pathogenesi
asthma
copd
cf
moreov
even
less
understood
regard
potenti
interkingdom
microbi
interact
may
impact
function
express
collect
microbiom
turn
host
respons
manifest
airway
diseas
oral
fungal
microbiom
recent
studi
healthi
individu
oral
rins
sampl
analyz
use
panfung
primer
follow
pyrosequenc
total
fungal
speci
identifi
given
individu
nine
known
cultur
speci
candida
spp
frequent
isol
subject
follow
genera
cladosporium
aureobasidium
saccharomycetal
aspergillu
fusarium
cryptococcu
four
genera
candida
cladosporium
aureobasidium
saccharomycetal
detect
least
ten
subject
particip
author
also
suggest
exist
basal
state
oral
mycobiom
consist
genera
present
least
studi
subject
howev
larg
number
divers
fungi
put
identifi
studi
identifi
genera
observ
across
sampl
find
provid
initi
baselin
studi
fungal
microbiota
along
respiratori
tract
demonstr
within
oral
caviti
hous
divers
bacteri
speci
divers
fungal
microbiota
coexist
futur
investig
fungal
mycobiom
respiratori
nich
lower
airway
potenti
relat
chronic
inflammatori
airway
diseas
would
great
interest
healthi
individu
nasopharyng
nich
appear
harbor
vari
yet
distinct
commun
microbiota
compar
oropharynx
predomin
phyla
repres
nostril
firmicut
actinobacteria
includ
bacteri
famili
staphylococcaea
propionibacteriacea
corynebacteriacea
oropharynx
predomin
phyla
firmicut
proteobacteria
bacteroidet
thu
nostril
oropharynx
exhibit
distinct
microbiota
distribut
phylum
level
former
similar
found
skin
latter
reminisc
distribut
gastrointestinalassoci
microbiota
howev
specif
region
sampl
nasopharynx
ie
outer
area
nostril
vs
inner
part
nasal
tract
may
influenc
distribut
observ
oropharyngealassoci
commun
also
note
sampl
obtain
posterior
aspect
nasal
caviti
oral
nasopharyng
microbiota
nonhealthi
state
recent
explor
charlson
et
al
examin
impact
cigarett
smoke
exposur
microbi
commun
found
two
nich
major
risk
factor
copd
cigarett
smoke
may
promot
microbi
colon
respiratori
infect
number
mechan
includ
disrupt
mucociliari
clearanc
enhanc
bind
bacteria
epitheli
cell
impair
host
immun
respons
rrna
pyrosequenc
analysi
sampl
asymptomat
current
smoker
healthi
nonsmok
demonstr
bacteri
commun
smoker
cluster
separ
nonsmok
smoker
exhibit
greater
variat
type
rel
abund
bacteria
inhabit
oropharynx
nasopharynx
indic
heterogen
potenti
divers
bacteri
commun
investig
identifi
specif
microbiota
appear
distinguish
smokingassoci
bacteri
commun
nonsmok
gener
level
oropharyng
sampl
presenc
capnocytophaga
megasphaera
veillonella
haemophiu
neisseria
spp
best
character
smokingassoci
commun
nasopharynx
smoker
also
demonstr
greater
rel
abund
sever
bacteri
famili
primarili
belong
firmicut
phylum
includ
aerococcacea
eubacteriacea
lachnospiracea
peptostreptococcacea
erysipelotrichacea
main
conclus
studi
smoke
exposur
alter
normal
microbiota
commun
structur
may
facilit
enhanc
pathogen
colon
upper
respiratori
tract
normal
commens
microbiota
shown
modul
host
immun
respons
respiratori
mucosa
set
infect
mycoplasma
pulmoni
influenza
viru
airway
microbiom
asthmarec
cultureindepend
studi
indic
resid
microbiota
commun
exist
lower
respiratori
tract
contrast
tradit
view
lower
airway
complet
steril
environ
healthi
individu
howev
remain
proven
definit
whether
detect
presenc
lower
airway
microbiota
appar
healthi
individu
repres
true
colon
lower
airway
presenc
transient
inhal
speci
regular
turnov
microbi
commun
oropharyng
contamin
collect
lower
airway
sampl
even
link
potenti
individu
incorrectli
categor
truli
healthi
given
practic
challeng
sampl
lower
airway
human
subject
distinguish
among
first
three
possibl
difficult
perhap
less
surpris
rich
microbi
commun
present
copd
airway
cultureindepend
analys
recent
find
also
demonstr
divers
commun
microbiota
bronchi
associ
chronic
stabl
asthma
use
tradit
rrna
clone
librari
sequenc
analysi
hilti
et
al
analyz
respiratori
sampl
adult
asthma
five
copd
eight
healthi
control
children
difficult
asthma
seven
control
although
clone
librari
approach
rrnabas
commun
analysi
provid
significantli
less
microbi
commun
resolut
compar
nextgener
sequenc
phylochip
affymetrix
corpor
santa
clara
ca
usa
microarray
method
pathogen
member
proteobacteria
phylum
particular
haemophilu
spp
commonli
found
bronchial
brush
adult
patient
airway
diseas
asthma
copd
compar
control
similarli
observ
analysi
bronchoalveolar
lavag
fluid
pediatr
asthma
patient
contrast
member
bacteroidet
phylum
especi
prevotella
spp
often
identifi
healthi
adult
control
notabl
asthmat
patient
studi
prescrib
corticosteroid
therapi
inhal
oral
unknown
effect
microbiom
studi
also
investig
potenti
geograph
differ
microbi
commun
upper
lower
respiratori
tract
compar
sampl
nasopharynx
np
oropharynx
left
upper
lung
lobe
lul
np
microbiota
appear
distinct
found
oropharynx
lul
among
patient
airway
diseas
asthma
copd
lul
microbi
commun
differ
found
lul
oropharynx
healthi
control
suggest
distinct
differ
commun
composit
diseas
bronchi
compar
healthi
state
interestingli
smoker
observ
lower
rrna
copi
number
rrna
copi
number
directli
compar
measur
bacteri
commun
divers
rich
ie
number
differ
phylotyp
sinc
bacteria
possess
multipl
copi
rrna
gene
interest
note
other
observ
smoker
exhibit
greater
variat
type
rel
abund
bacteria
inhabit
nasal
oropharynx
compar
nonsmok
despit
limit
small
sampl
size
limit
analysi
potenti
differ
airway
microbiota
asthmat
copd
subject
unknown
potenti
impact
corticosteroid
use
find
studi
suggest
characterist
bacteri
microbiota
may
colon
lower
airway
patient
stabl
asthma
larger
studi
asthmat
nonasthmat
healthi
adult
chronic
stabl
asthma
also
found
associ
differ
composit
structur
bronchial
microbiota
commun
compar
healthi
subject
huang
et
al
examin
microbi
commun
sampl
triplic
protect
specimen
bronchial
brush
use
highdens
bacteri
microarray
rrna
phylochip
well
quantit
pcr
analysi
phylochip
platform
capabl
detect
approxim
bacteri
taxa
parallel
owe
natur
assay
hybrid
base
lowand
highabund
commun
member
detect
equal
effici
permit
highresolut
profil
commun
gener
asthmat
subject
exhibit
greater
bacteri
burden
significantli
higher
bacteri
divers
bronchial
microbiota
commun
asthmat
studi
stabl
mildtomoder
diseas
take
standard
inhal
corticosteroid
therapi
studi
investig
potenti
relationship
characterist
microbi
commun
clinic
featur
asthma
independ
analys
bacteri
divers
microbiota
commun
composit
strongli
correl
bronchial
hyperrespons
particular
greater
bronchial
hyperrespons
highli
correl
rel
abund
approxim
specif
bacteri
phylotyp
includ
bacteri
famili
within
proteobacteria
oxalobacteracea
pseudomonadacea
sphingomonadacea
comamonadacea
figur
mani
repres
speci
famili
possess
either
pathogen
potenti
chemic
function
conceiv
could
contribut
known
pathophysiolog
process
asthma
find
thu
may
particular
interest
suggest
possibl
function
interact
specif
compon
airway
microbiom
host
may
impact
pathophysiolog
featur
asthma
airway
microbiom
copdin
copd
bacteri
colon
infect
lower
airway
long
note
cultur
method
recent
cultureindepend
investig
rrna
analysi
approach
reveal
much
greater
commun
rich
copd
airway
previous
appreci
phylochipbas
studi
copd
patient
hospit
respiratori
failur
owe
sever
exacerb
bacteri
taxa
identifi
lower
airway
sampl
addit
bacteri
famili
contain
typic
pathogen
associ
copd
exacerb
eg
pasteurelleaceaeh
influenza
pseudomonadaceaep
aeruginosa
streptococcacea
pneumonia
moraxellaceaem
catarrhali
multitud
famili
potenti
pathogen
member
speci
identifi
includ
member
enterobacteriacea
burkholderiacea
mycoplasmatacea
alteromondacea
mani
other
copd
patient
sampl
harbor
averag
bacteri
taxa
despit
concurr
receiv
broadspectrum
antimicrobi
therapi
addit
core
microbiota
compris
taxa
present
subject
identifi
repres
distinct
famili
eg
pseudomonadacea
enterobacteriacea
campylobacteracea
helicobacteracea
other
includ
mani
potenti
pathogen
speci
although
highli
select
cohort
sever
exacerb
copd
patient
harbor
p
aeruginosa
patient
cluster
two
separ
group
distinguish
signific
differ
commun
rich
patient
richer
bacteri
commun
receiv
ventilatori
support
significantli
shorter
durat
microbiota
commun
commonli
popul
member
clostridiacea
lachnospiracea
bacillacea
peptostreptococcacea
mani
repres
normal
commens
microbiota
upper
respiratori
tract
may
help
maintain
commun
stabil
function
homeostasi
microbiom
observ
gut
find
suggest
member
airway
microbiota
commun
typic
respiratori
pathogen
may
import
role
determin
state
clinic
instabl
stabil
copd
comparison
lower
airway
microbiota
among
patient
copd
healthi
smoker
without
evid
copd
nonsmok
control
perform
analysi
bronchoalveolar
lavag
fluid
collect
subject
four
copd
seven
smoker
normal
spirometri
three
healthi
nonsmok
four
copd
subject
three
mild
obstruct
diseas
one
sever
diseas
global
health
initi
obstruct
lung
diseas
stage
criteria
although
subject
number
small
nonsmok
control
demonstr
heterogen
lower
airway
bacteri
commun
similar
observ
healthi
nonsmok
two
copd
patient
mild
diseas
contrast
limit
bacteri
commun
divers
observ
two
copd
patient
one
sever
diseas
across
subject
predomin
phyla
found
lung
proteobacteria
firmicut
bacteroidet
also
observ
studi
author
suggest
exist
core
pulmonari
microbiom
healthi
subject
compris
bacteri
genera
greatest
number
sequenc
read
studi
includ
pseudomona
streptococcu
prevotella
fusobacterium
spp
final
microanatom
geograph
differ
microbiota
composit
may
exist
diseas
lung
analysi
copd
lung
explant
differ
bacteri
commun
composit
note
depend
bronchu
sampl
within
lung
speci
highli
associ
microanatom
variat
commun
composit
includ
haemophilu
stenotrophomona
pseudomona
spp
suggest
organ
may
repres
keyston
speci
drive
ecosystem
function
result
defin
commun
composit
host
respons
discret
nich
moreov
data
suggest
similar
gi
tract
nichespecif
microbiota
also
exist
airway
airway
microbiom
cfcultureindepend
effort
field
cf
airway
microbiota
rel
longer
histori
accumul
bodi
literatur
anecdot
evid
clinic
laboratori
coexist
multipl
speci
airway
cf
patient
prompt
roger
colleagu
perform
first
cultureindepend
analysi
adult
cf
patient
bronchoscop
sputum
sampl
demonstr
multipl
distinct
rrna
pcr
product
present
patient
sampl
indic
presenc
distinct
bacteri
phylotyp
nich
moreov
subsequ
sequenc
effort
identifi
addit
p
aeruginosa
stenotrophomona
smaltophilia
multipl
speci
typic
associ
oral
gastrointestin
caviti
includ
prevotellaori
fusobacterium
gonidoforman
bacteroid
fragili
amongst
other
speci
previous
associ
cf
airway
investig
provid
semin
followup
studi
base
rna
rather
dna
profil
activ
member
cf
airway
microbiota
adult
patient
total
rna
extract
sputum
sampl
revers
transcrib
use
templat
rrna
pcr
amplif
amplicon
gener
approach
repres
viabl
commun
member
activ
transcrib
rrna
gene
profil
amplicon
identifi
distinct
band
origin
viabl
bacteri
member
cf
airway
thu
provid
first
evid
activ
divers
airway
microbiota
chronic
pulmonari
diseas
across
patient
sampl
bacteri
commun
rich
number
distinct
phylotyp
detect
high
viabl
phylotyp
one
patient
substanti
greater
typic
one
two
pulmonari
pathogen
report
culturebas
clinic
laboratori
test
colon
cf
airway
followup
clone
effort
three
patient
studi
sequenc
clone
identifi
presenc
addit
speci
previous
identifi
cf
airway
includ
two
abiotrophia
speci
mycoplasma
salivarium
ralstoniataiwanensi
rothiamucilaginosa
treponemavincentii
veillonellaatypicai
semin
studi
demonstr
divers
viabl
bacteri
speci
typic
associ
cf
airway
present
patient
could
put
contribut
airway
diseas
groundbreak
work
laid
foundat
number
subsequ
studi
dramat
expand
understand
airway
microbiota
subsequ
cultureindepend
studi
use
progress
higherresolut
tool
reveal
even
complex
divers
microbiota
airway
cf
patient
studi
expand
divers
organ
detect
airway
cf
patient
howev
necessari
determin
relationship
composit
assemblag
host
health
statu
mean
identifi
key
featur
microbiom
contribut
patient
health
crosssect
studi
respiratori
sampl
collect
clinic
stabl
cf
patient
age
month
year
receiv
antibiot
acut
pulmonari
exacerb
within
month
sampl
collect
cox
colleagu
examin
chang
airway
microbiota
composit
within
agestratifi
crosssect
studi
demonstr
signific
neg
correl
p
exist
patient
age
pulmonari
function
confirm
compar
younger
popul
older
cf
patient
cohort
exhibit
poorer
airway
health
author
also
found
compar
younger
patient
older
individu
exhibit
signific
loss
bacteri
commun
rich
number
type
bacteria
present
even
rel
distribut
commun
member
divers
index
calcul
base
rich
even
metric
addit
commun
present
airway
older
cf
patient
compris
phylogenet
relat
organ
primarili
belong
famili
pseudomonadacea
studi
demonstr
chronic
inflammatori
diseas
gi
tract
associ
loss
bacteri
divers
domin
commun
hand
speci
airway
microbiota
exhibit
hallmark
cf
patient
sever
inflammatori
statu
limit
studi
includ
crosssect
natur
specimen
type
examin
expector
sputum
deep
throat
swab
adult
pediatr
patient
respect
although
specimen
alway
subject
contamin
oral
microbiota
standard
type
sampl
obtain
clinic
infer
airway
microbiolog
treat
cf
patient
nonetheless
studi
provid
first
evid
airway
microbiota
composit
associ
airway
function
statu
suggest
microbiota
composit
could
provid
robust
diagnost
prognost
marker
airway
health
potenti
import
contribut
role
oropharyngealassoci
microbiota
lower
airway
diseas
overlook
find
lower
respiratori
tract
specimen
organ
typic
associ
oropharynx
alway
rais
question
oral
contamin
howev
may
necessarili
case
sinc
recent
evid
suggest
presenc
speci
airway
may
wholli
innocu
given
complex
airway
microbiota
reveal
associ
chronic
airway
diseas
particularli
cf
interact
among
microbi
commun
undoubtedli
occur
like
affect
function
phenotyp
express
one
organ
includ
microbiota
commun
collect
whole
two
studi
elegantli
demonstr
pathogen
contribut
oropharyng
flora
presenc
primari
pathogen
name
p
aeruginosa
use
rat
lung
infect
model
duan
colleagu
show
pulmonari
damag
significantli
enhanc
anim
coinfect
p
aeruginosa
oropharyng
flora
isol
cf
patient
compar
infect
p
aeruginosa
alon
mediat
quorum
sens
led
upregul
number
p
aeruginosa
virul
factor
similar
find
observ
recent
studi
investig
group
polymicrobi
infect
drosophila
melanogast
model
use
oropharyngealderiv
strain
pathogen
host
significantli
worsen
fli
surviv
coinfect
p
aeruginosa
strain
perform
thu
find
oropharyngealassoci
bacteri
microbiota
lower
airway
automat
constru
innocu
bystand
airway
diseas
move
age
highthroughput
omic
new
tool
develop
provid
comprehens
profil
speci
present
given
commun
well
function
capac
express
profil
collect
pangenom
provid
unparallel
insight
relationship
human
host
microbi
inhabit
though
nichespecif
exist
discret
nich
comfort
alreadi
begin
observ
consist
trend
data
gener
across
mucos
surfac
distinct
anatom
nich
human
host
exampl
chronic
inflamm
either
gi
tract
airway
result
reduc
microbiota
divers
site
though
composit
deplet
microbiota
distinct
nich
specif
probabl
driven
local
select
pressur
clearli
great
need
highli
integr
translat
research
effort
across
larg
cohort
patient
howev
recent
develop
molecular
tool
platform
provid
comprehens
microbi
profil
necessari
interrog
complex
commun
inhabit
human
mucos
surfac
field
airway
microbiota
research
pois
expans
studi
address
key
gap
understand
airway
health
dogma
hand
bacteri
speci
associ
chronic
airway
diseas
supplant
recent
cultureindepend
studi
reveal
airway
microbiom
obstruct
pulmonari
diseas
patient
repres
far
divers
consortium
bacteri
speci
previous
believ
import
note
previou
dogma
primarili
base
data
gener
era
predat
applic
sensit
cultureindepend
tool
microbi
commun
profil
particularli
pertin
given
major
known
bacteri
speci
current
uncultur
convent
laboratori
condit
emerg
cultureindepend
data
suggest
respiratori
microbiota
differ
state
pulmonari
diseas
health
diseas
sever
strongli
suggest
demonstr
gastrointestin
microbiota
shift
airway
microbiom
composit
may
drive
specif
immunophenotyp
associ
distinct
chronic
airway
diseas
thu
emerg
field
open
possibl
microbiota
manipul
novel
therapeut
strategi
treatment
manag
chronic
airway
diseas
initi
investig
cf
airway
microbiota
suggest
relationship
airway
microbiom
composit
sever
diseas
build
upon
recent
studi
chronic
airway
diseas
futur
investig
airway
microbiom
differ
diseas
phenotyp
across
gradient
diseas
sever
particularli
asthmat
copd
cf
popul
like
identifi
microbi
driver
diseas
state
potenti
lead
improv
patient
stratif
patienttailor
therapi
although
phylogenet
profil
provid
us
wealth
inform
divers
speci
present
airway
microbiota
function
studi
better
establish
link
microbiom
behavior
host
immun
respons
provid
better
understand
pathophysiolog
process
chronic
inflammatori
diseas
airway
develop
applic
tool
airway
microbiom
profil
structur
function
level
rapid
studi
integr
highresolut
tool
appropri
welldesign
clinic
studi
includ
larger
subject
number
encompass
health
diseas
state
ascrib
particular
attent
airway
sampl
sourc
confirm
disprov
current
evid
color
repres
differ
bacteri
famili
taxa
member
speci
previous
associ
clinic
diseas
possess
notabl
function
featur
unclassif
unclassifi
reproduc
permiss
tabl
bacteri
speci
commonli
associ
cystic
fibrosi
airway
diseas
clinic
signific
ref
one
import
cf
infecti
agent
initi
nonmucoid
strain
give
rise
highli
antibioticresist
mucoid
strain
form
biofilm
refractori
mucocillari
clearanc
host
respons
antimicrobi
haemophilu
influenza
isol
frequent
young
patient
chronic
colon
airway
persist
extend
period
timeassoci
antibioticresist
hypermut
strain
staphylococcu
aureu
frequent
recov
cf
airway
patient
chronic
infect
dynam
exhibit
peak
adolesc
burkholderia
cepacia
complex
group
least
burkholderia
speci
import
opportunist
pathogen
caus
progress
invas
fatal
pulmonari
diseas
known
cepacia
syndrom
stenotrophomona
maltophilia
frequent
isol
midtol
adolesc
cf
airway
chronic
infect
unusu
case
achromobact
xylosoxidan
emerg
cf
pathogen
detect
increas
frequenc
cf
sputum
sampl
result
chronic
infect
antimicrobi
resist
isol
nontubercul
mycobacterium
nontubercul
mycobacterium
associ
coinfect
stenotrophomona
aspergillu
speci
patient
chronic
mycobacterium
abscessu
infect
exhibit
greater
rate
lung
function
declin
nontubercul
mycobacterium
infect
streptococcu
pneumonia
isol
frequent
pediatr
cf
patient
associ
pulmonari
exacerb
cf
cystic
fibrosi
expert
rev
respir
med
author
manuscript
avail
pmc
octob
